676 related articles for article (PubMed ID: 26617217)
1. Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases.
Buendia I; Michalska P; Navarro E; Gameiro I; Egea J; León R
Pharmacol Ther; 2016 Jan; 157():84-104. PubMed ID: 26617217
[TBL] [Abstract][Full Text] [Related]
2. Modulation of mitochondrial dysfunction in neurodegenerative diseases via activation of nuclear factor erythroid-2-related factor 2 by food-derived compounds.
Denzer I; Münch G; Friedland K
Pharmacol Res; 2016 Jan; 103():80-94. PubMed ID: 26626189
[TBL] [Abstract][Full Text] [Related]
3. Role of the Keap1/Nrf2 pathway in neurodegenerative diseases.
Yamazaki H; Tanji K; Wakabayashi K; Matsuura S; Itoh K
Pathol Int; 2015 May; 65(5):210-9. PubMed ID: 25707882
[TBL] [Abstract][Full Text] [Related]
4. Licochalcone E activates Nrf2/antioxidant response element signaling pathway in both neuronal and microglial cells: therapeutic relevance to neurodegenerative disease.
Kim SS; Lim J; Bang Y; Gal J; Lee SU; Cho YC; Yoon G; Kang BY; Cheon SH; Choi HJ
J Nutr Biochem; 2012 Oct; 23(10):1314-23. PubMed ID: 22227268
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death.
Kumar H; Koppula S; Kim IS; More SV; Kim BW; Choi DK
CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):1015-29. PubMed ID: 23244425
[TBL] [Abstract][Full Text] [Related]
6. The role of modulation of antioxidant enzyme systems in the treatment of neurodegenerative diseases.
Obuobi S; Karatayev S; Chai CL; Ee PL; Mátyus P
J Enzyme Inhib Med Chem; 2016; 31(sup3):194-204. PubMed ID: 27389167
[TBL] [Abstract][Full Text] [Related]
7. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents.
Giudice A; Arra C; Turco MC
Methods Mol Biol; 2010; 647():37-74. PubMed ID: 20694660
[TBL] [Abstract][Full Text] [Related]
8. [Role of Nrf2 in neurodegenerative diseases and recent progress of its activators].
Zhao CY; Wang XL; Peng Y
Yao Xue Xue Bao; 2015 Apr; 50(4):375-84. PubMed ID: 26223117
[TBL] [Abstract][Full Text] [Related]
9. Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.
Johnson DA; Johnson JA
Free Radic Biol Med; 2015 Nov; 88(Pt B):253-267. PubMed ID: 26281945
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Nrf2 signaling pathway using phytochemical ingredients: A novel therapeutic road map to combat neurodegenerative diseases.
Bai X; Bian Z; Zhang M
Phytomedicine; 2023 Jan; 109():154582. PubMed ID: 36610130
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis.
Cheng X; Ku CH; Siow RC
Free Radic Biol Med; 2013 Sep; 64():4-11. PubMed ID: 23880293
[TBL] [Abstract][Full Text] [Related]
12. Nrf2 Pathway in Age-Related Neurological Disorders: Insights into MicroRNAs.
Paladino S; Conte A; Caggiano R; Pierantoni GM; Faraonio R
Cell Physiol Biochem; 2018; 47(5):1951-1976. PubMed ID: 29969760
[TBL] [Abstract][Full Text] [Related]
13. Nrf2 in health and disease: current and future clinical implications.
Al-Sawaf O; Clarner T; Fragoulis A; Kan YW; Pufe T; Streetz K; Wruck CJ
Clin Sci (Lond); 2015 Dec; 129(12):989-99. PubMed ID: 26386022
[TBL] [Abstract][Full Text] [Related]
14. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?
de Vries HE; Witte M; Hondius D; Rozemuller AJ; Drukarch B; Hoozemans J; van Horssen J
Free Radic Biol Med; 2008 Nov; 45(10):1375-83. PubMed ID: 18824091
[TBL] [Abstract][Full Text] [Related]
15. The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease.
Calkins MJ; Johnson DA; Townsend JA; Vargas MR; Dowell JA; Williamson TP; Kraft AD; Lee JM; Li J; Johnson JA
Antioxid Redox Signal; 2009 Mar; 11(3):497-508. PubMed ID: 18717629
[TBL] [Abstract][Full Text] [Related]
16. Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases.
Singh S; Vrishni S; Singh BK; Rahman I; Kakkar P
Free Radic Res; 2010 Nov; 44(11):1267-88. PubMed ID: 20815789
[TBL] [Abstract][Full Text] [Related]
17. The role of Nrf2 in oxidative stress-induced endothelial injuries.
Chen B; Lu Y; Chen Y; Cheng J
J Endocrinol; 2015 Jun; 225(3):R83-99. PubMed ID: 25918130
[TBL] [Abstract][Full Text] [Related]
18. The Nrf2 Signaling in Retinal Ganglion Cells under Oxidative Stress in Ocular Neurodegenerative Diseases.
Liu XF; Zhou DD; Xie T; Hao JL; Malik TH; Lu CB; Qi J; Pant OP; Lu CW
Int J Biol Sci; 2018; 14(9):1090-1098. PubMed ID: 29989056
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation.
Hybertson BM; Gao B; Bose SK; McCord JM
Mol Aspects Med; 2011 Aug; 32(4-6):234-46. PubMed ID: 22020111
[TBL] [Abstract][Full Text] [Related]
20. NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches.
Sivandzade F; Prasad S; Bhalerao A; Cucullo L
Redox Biol; 2019 Feb; 21():101059. PubMed ID: 30576920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
